Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine | NEJM
Original Article from The New England Journal of Medicine — Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Original Article from The New England Journal of Medicine — Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
Arexvy is currently approved to prevent lower respiratory tract disease (LRTD) caused by RSV in individuals aged 60 years and older, and those 50 to…
The approval was supported by data from the randomized, double-blind, placebo-controlled, event-driven phase 3 FINEARTS-HF study.
We know it can be difficult to keep up with emerging research, conference news, and guideline updates. Enter the Grand Roundup: a hyper-focused, curated
The USPSTF meets several times a year to review the latest science and decide which screenings, medications and other preventive services should be fully covered…
In this month’s case, an error went unrecognized for months despite numerous opportunities for its discovery.
Agency says these fees place an additional burden on taxpayers who already fund the underlying research.
The FDA is expected to decide on treatments for bronchiectasis, chronic immune thrombocytopenia, fibromyalgia, Friedreich ataxia, and recurrent respiratory papillomatosis.
The lawsuit was prompted by several recent HHS actions the plaintiffs noted were “designed to mislead, confuse, and gradually desensitize the public to anti-vaccine and…
We spoke with Dr Kellan Baker of the Whitman-Walker institute to shed some light on the many changes taking place to various aspects of medical…
We know it can be difficult to keep up with emerging research, conference news, and guideline updates. Enter the Grand Roundup: a hyper-focused, curated